Article Text

PDF
Letter
Individualised surveillance strategies for colorectal cancer in inflammatory bowel disease
  1. Judith E Baars1,
  2. Caspar W N Looman2,
  3. Ewout W Steyerberg2,
  4. Ernst J Kuipers1,3,
  5. Christien J van der Woude1
  1. 1Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands
  2. 2Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
  3. 3Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands
  1. Correspondence to Dr J E Baars, Department of Gastroenterology and Hepatology, Erasmus MC, 's Gravendijkwal 230, Room Ba 393, 3015 CE Rotterdam, The Netherlands; j.baars{at}erasmusmc.nl

Statistics from Altmetric.com

We read with interest the updated guidelines for colorectal cancer (CRC) screening and surveillance in moderate and high risk groups from Cairns SR et al.1 Indeed risk stratification is an important step forward for inflammatory bowel disease (IBD)-related …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.